Lucid Diagnostics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lucid Diagnostics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q3 2024.
  • Lucid Diagnostics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.86M, a 79.4% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.86M +$1.27M +79.4% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $3.04M +$1.2M +65.5% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.04M -$845K -44.9% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.31M -$701K -34.9% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $1.59M -$408K -20.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.84M -$245K -11.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.88M -$340K -15.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.01M Dec 31, 2022 10-K 2024-03-25
Q3 2022 $2M Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.08M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $2.22M Mar 31, 2022 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.